Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4530

1.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, CasĂ  L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
2.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
3.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
4.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
5.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
6.

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.

Breast Cancer. 2005;12(3):203-10.

7.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

PMID:
19364968
8.

The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.

Asoglu O, Ozmen V, Karanlik H, Kecer M, Muzlumznoglu M, Igci A, Parlak M.

Acta Chir Belg. 2005 May-Jun;105(3):291-6.

PMID:
16018523
9.
10.

Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.

Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L.

Eur J Surg Oncol. 2003 Apr;29(3):221-3.

PMID:
12657230
11.

Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?

Chua B, Ung O, Taylor R, Boyages J.

ANZ J Surg. 2002 Nov;72(11):786-92.

PMID:
12437688
12.

Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.

Breast J. 2004 Mar-Apr;10(2):101-5.

PMID:
15009035
13.

Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.

Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB.

J Surg Oncol. 2006 Feb 1;93(2):129-32.

PMID:
16425295
14.

Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.

Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Eur J Surg Oncol. 2009 Aug;35(8):805-13. doi: 10.1016/j.ejso.2008.09.006. Epub 2008 Nov 28.

PMID:
19046846
15.

Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.

Chung MH, Ye W, Giuliano AE.

Ann Surg Oncol. 2001 Oct;8(9):688-92.

PMID:
11597008
16.

Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.

Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P.

J Am Coll Surg. 1999 Mar;188(3):248-54.

PMID:
10065813
17.

Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.

Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC.

Am J Surg. 2002 Jan;183(1):23-7.

PMID:
11869698
18.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group.

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
19.

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.

Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR.

Ann Surg Oncol. 2004 Sep;11(9):846-53. Epub 2004 Aug 16.

PMID:
15313737
20.

Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.

Takei H, Suemasu K, Kurosumi M, Horii Y, Yoshida T, Ninomiya J, Yoshida M, Hagiwara Y, Kamimura M, Hayashi Y, Inoue K, Tabei T.

Breast Cancer. 2007;14(1):16-24.

Supplemental Content

Support Center